Vanda Bostikova

Dr. Vanda Bostikova


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
AMAdam MacNeil
Adam MacNeil
MRMary Reynolds
Mary Reynolds
ZBZach Braden
Zach Braden
DCDarin S. Carroll
Darin S. Carroll
VBVanda Bostik
Vanda Bostik
IDInger K. Damon
Inger K. Damon
During a suspected monkeypox outbreak in the Republic of Congo, we documented transmission of varicella-zoster virus (VZV) infection with palm and so

15 April 2004 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
RARama Rao Amara
Rama Rao Amara
PNPragati Nigam
Pragati Nigam
SSSunita Sharma
Sunita Sharma
JLJinyan Liu
Jinyan Liu
VBVanda Bostik
Vanda Bostik
The currently used smallpox vaccine is associated with a high incidence of adverse events, and there is a serious need for a safe and effective alternative vaccine. Here, we carried out a longitudinal evaluation of vaccinia virus-specific CD4 and CD8 T cells in smallpox-vaccinated individuals by using a highly sensitive intracellular cytokine staining assay. Our results demonstrate that, in addition to the CD8 response, the smallpox vaccinations raised a robust CD4 response with a Th1-dominant cytokine profile. These CD4 T cells were stable and exhibited only a twofold contraction between peak effector and memory phases compared with an approximate sevenfold contraction for CD8 cells. A significant proportion of vaccinated individuals lost detectable CD8 memory while maintaining CD4 memory. After a booster immunization, these individuals generated a robust CD8 response, which some of them rapidly lost. Thus, the current smallpox vaccine provides long-lasting CD4 help that may be critical for long-lived B-cell memory. We suggest that the provision of adequate CD4 help for CD8 and humoral effector functions will be critical to the success of the next generation of smallpox vaccines.

28 September 2017 in APMIS
Verified
Journal Article
Closed access
PDF file
PCPavel Cermak
Pavel Cermak
JOJana Olsovska
Jana Olsovska
AMAlexandr Mikyška
Alexandr Mikyška
MDMartin Dusek
Martin Dusek
ZKZuzana Kadleckova
Zuzana Kadleckova
PBPavel Bostik
Pavel Bostik

1 December 2007 in Journal of Virology
Verified
Journal Article
Closed access
VLVladimir N. Loparev
Vladimir N. Loparev
ERElena N. Rubtcova
Elena N. Rubtcova
VBVanda Bostik
Vanda Bostik
DGDhwani Govil
Dhwani Govil
CBChristopher J. Birch
Christopher J. Birch
MCMargaret C. Croxson
Margaret C. Croxson
Whole genome phylogenetic analysis in this study resolved a total of five major genotypes among the 22 varicella-zoster virus (VZV) strains or isolates for which complete genomic sequences are available. Consistent with earlier publications we have designated these genotypes European 1 (E1), European 2 (E2), Japanese (J), mosaic 1 (M1), and mosaic 2 (M2). Single nucleotide polymorphism (SNP) analysis performed in a whole-genome alignment revealed that VZV isolates of all five genotypes can be accurately genotyped using SNPs from two amplicons: open reading frame 22 (ORF22) and either ORF21 or ORF50. This modified approach identifies all of the genotypes observed using any of the published genotyping protocols. Of 165 clinical varicella and zoster isolates from Australia and New Zealand typed using this approach, 67 of 127 eastern Australian isolates were E1, 30 were E2, 16 were J, 10 were M1, and 4 were M2; 25 of 38 New Zealand isolates were E1, 8 were E2, and 5 were M1. VZV strain diversity in eastern Australia is thus broader than has been described for any other region, including Europe, Africa, and North America. J strains were far more prevalent than previously observed in countries other than Japan. Two-amplicon typing was in complete accord with genotypes derived using SNP in multiple ORFs (ORFs 1, 21, 22, 38, 50, 54, and 62). Two additional minor genotypes, M3 and M4, could also be resolved using two-amplicon typing.

15 November 2008 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
MLMyron J. Levin
Myron J. Levin
RDRoberta L. DeBiasi
Roberta L. DeBiasi
VBVanda Bostik
Vanda Bostik
DSD. Scott Schmid
D. Scott Schmid
A previously healthy boy who had received varicella vaccine developed herpes zoster with meningitis. The vaccine strain recovered from scabs of 3 skin lesions had the wild-type allele at position 108111, a vaccine marker never previously associated with vaccine-associated adverse events. The vaccine strain from cerebrospinal fluid also contained mutations never previously observed at vaccine-associated single nucleotide polymorphisms that would alter amino acid sequences in ORF54 and ORF59. The presence of distinct strains in skin lesions and cerebrospinal fluid indicate that >1 variant strain may reactivate to cause herpes zoster.

1 January 2009 in Virology
Verified
Journal Article
Closed access
VLVladimir N. Loparev
Vladimir N. Loparev
ERElena N. Rubtcova
Elena N. Rubtcova
VBVanda Bostik
Vanda Bostik
VTValentina Tzaneva
Valentina Tzaneva
ASAndreas Sauerbrei
Andreas Sauerbrei
DSD. Scott Schmid
D. Scott Schmid